Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023 : a systematic analysis for the Global Burden of Disease Study 2023

Flor, L.S. and Spencer, C.N. and Cagney, J. and Gil, G.F. and Aalruz, H. and ElHafeez, S. and Abdelwahab, S.I. and Abdoun, M. and Abebe, M. and Abebe, Y. and Abedi, A. and Abeldaño Zuñiga, R.A. and Abie, A. and Abiodun, O. and Aboagye, R.G. and Abreu, L.G. and Abu Farha, R.K. and Abubakar, B. and Abuhammad, S. and Achore, M. and Adams, L.C. and Adebiyi, B.O. and Adedokun, K.A. and Adegbile, O.E. and Adegoke, N.A. and Adeleke, O.T. and Adeniyi, M.A. and Adesina, M.A. and Adewuyi, H.O. and Adnani, Q.E.S. and Adzigbli, L.A. and Afolabi, A.A. and Afolabi, R.F. and Afzal, M.S. and Afzal, S. and Agyemang-Duah, W. and Ahinkorah, B.O. and Ahmad, A. and Ahmad, D. and Ahmad, M.M. and Ahmed, A. and Ahmed, H. and Ahmed, M.S. and Ahmed, O. and Akin-Odanye, E.O. and Akosile, W. and Akpabio, I.U. and Alam, Z. and Al-Amer, R.M. and Alansari, A.N. and Alanzi, T.M. and Aleidi, S.M. and Alemu, M.B. and Naji Alhalaiqa, F.N. and AL-Iede, M. and Alinejad-Rokny, H. and Almagharbeh, W.T. and Al-Mamun, M. and Almazan, J.U. and Alnaeem, M.M. and Alrimawi, I. and Z Alshahrani, N.Z. and Alyahya, M.S.I. and Amin, T.T. and Amini, S. and Amiri, S. and Amu, H. and Amzat, J. and Anderson, D.B. and Anuoluwa, B.S. and Anvari, S. and Anyasodor, A.E. and Aravkin, A.Y. and Arias de la Torre, J. and Armocida, B. and Arrieta, A. and Arumuganainar, D. and Ashraf, T. and Aslam, B. and Asri, Y. and Athari, S.S. and Atorkey, P. and Atre, S.R. and Atsbaha, A.H. and Atta, J.A. and Atteraya, M.S. and Azzam, A.Y. and Sheeba, B. and Baghlaf, K.K. and Baig, A.A. and Balcha, W.F. and Balmori-de-la-Miyar, J. and Bandyopadhyay, S. and Barik, M. and Barker-Collo, S.L. and Bashar, M.D.A. and Bashir, S. and Bashiri, A. and Bastan, M.-M. and Beeraka, N.M. and Belayneh, M. and Belge Bilgin, G. and Bell, M.L. and Berihun, A.A. and Bermudez, A.N.C. and Bhatnagar, A. and Bhattarai, A.H. and Biswas, M.S. and Bjertness, E. and Bolarinwa, O.A. and Bolourinejad, P. and Boppana, S.H. and Botero Carvajal, A. and Bouaoud, S. and Brugha, T. and Buonsenso, D. and Burns, R.A. and Bustanji, Y. and Carugno, A. and Carvalho, A.F. and Carvalho, F. and Castaldelli-Maia, J.M. and Cerrai, S. and Chandan, J.S. and Chandradasa, M. and Charalampous, P. and Chattu, V.K. and Chaudhary, A.A. and Chaudhuri, S. and Chen, H. and Ching, P.R. and Chopra, H. and Chukwu, C.W. and Chukwu, I.S. and Chung, S. and Cullen, P. and da Silva, A.G. and Dachew, B.A. and Dadras, O. and Dai, X. and Dalal, K. and Dandona, R. and D'Anna, L. and Darcho, S.D. and Dayal, H. and DeGraw, E.M. and Dellie, E. and Deuba, K. and Dewan, S.M.R. and Dias Da Silva, D. and Diaz, D. and Dohare, S. and Dowou, R.K. and Dumbili, E.W. and Dunne, J. and Eboreime, E. and Edeh, C. and Edinur, H.A. and Ekholuenetale, M. and El Morsi, D.A.W. and Eshun, G. and Fagbamigbe, A.F. and Fan, Q. and Farahani, A. and Faro, A. and Fasanmi, A.O. and Feizkhah, A. and Ferreira, N. and Franklin, R.C. and Fry, D.A. and Gao, X. and Gebregergis, M.W. and Gebrehiwot, M. and Geda, Y.F. and Gelchu, M. and a Getahun, G.K. and Ghasemi Assl, S. and Gholami, E. and Gholizadeh, N. and Ghotbi, E. and Gilani, J.A. and Girmay, A.A. and Golechha, M. and Goleij, P. and Grivna, M. and Guan, S.-Y. and Gunawardane, D.A. and Gupta, S. and Halder, P. and Mosa, H.M. and Hanif, A. and Hanifi, N. and Endashaw Hareru, H.E. and Haro, J.M. and Has, E.M.M. and Hasaballah, A.I. and Hasani, H. and Hay, S.I. and Herbert, M.E. and Hesari, M. and Hlongwa, M. and Hossain, M.S. and Hossain, M.S. and Hossain, M.S. and Hossain, M.B. and Hu, C. and Huang, J. and Huang, Y. and Iftikhar, P.M. and Iqbal, M. and Irham, L.M. and Iskander, T.R. and Islam, M.S. and Islam, S.M.S. and Jabbarinejad, R. and Jena, B.H. and Jha, R.P. and Joseph, N. and Joshua, C.E. and Kang, J. and Kanmodi, K.K. and Karajizadeh, M. and Karami, J. and Kashoo, F.Z. and Khaing, I.K. and Khajuria, H. and Khalil, M. and Khan, I.H. and Khan, R.M. and Khanmohammadi, S. and Khasbage, S.U. and Kheirallah, K.A. and Khoshvaght, S. and Khosrowjerdi, M. and Khubchandani, J. and Kim, J. and Kim, K. and Knaul, F.M. and Knudsen, A.K.S. and Koomson-Yalley, E. and Kretchy, I.A. and Krishan, K. and Kuate Defo, B. and Kuddus, M. and Kuitunen, I. and Kulimbet, M. and Kumar, D. and Kumar, G.A. and Kumar, K. and Kumar, M. and Kumar, R. and Kumar, V. and Kusi-Amponsah Diji, A. and Kusnali, A. and Kuwornu, J.P. and Kyei-Arthur, F. and Pallavi, L.C. and Laflamme, L. and Lahariya, C. and Lajunen, T. and Langguth, B. and Laslett, A.-M. and Lassi, Z.S. and Latif, A. and Lawal, S.A. and Lawan, A. and Lee, S.W. and Leshargie, C.T. and Li, J. and Li, Z. and Liu, J. and Liu, X. and Llanaj, E. and Loreche, A.M. and Ma, K.S.-K. and Ma, Z.F. and Madadizadeh, F. and Madureira-Carvalho, A.M. and Mahmood, N.H. and Makram, A.M. and Mallick, T. and Carvalho Malta, D.C. and Manjani, L. and Maravilla, J.C. and Marzouk, S. and Matei, C.N. and Mathangasinghe, Y. and Mattoo, K.A. and Maulik, P.K. and Mbachu, I.I. and McLaughlin, S.A. and McPhail, S.M. and Meles, H.N. and Mendoza, W. and Menezes, R.G. and Mengesha, E.W. and Meštrović, T. and Mettananda, S. and Mewoabi, S.D.D. and Michelerio, A. and Miller, T.R. and Minervini, G. and Mirghafourvand, M. and Mittal, C. and Mohamed, M.G. and Mohamed, N.S. and Mohamed Ahmed, K.A.H. and Mohammad-Alizadeh-Charandabi, S. and Mohammadian-Hafshejani, A. and Mohammed, S. and Mokdad, A.H. and Molavi Vardanjani, H. and Monasta, L. and Moradi, Y. and Moreira, R.S. and Motappa, R. and Mozahheb Yousefi, K. and Mubarik, S. and Mujica, O.J. and Mullany, E.C. and Murray, C.J.L. and Myung, W. and Nagarajan, K. and Nargus, S. and Nashwan, A.J. and Nassar, M. and Navaratna, S.N.K. and Nayak, B.P. and Nayak, S.G. and Nazri-Panjaki, A. and Ndungu, A.W. and Nearchou, F. and Nega, A.T. and Negoi, I. and Nguyen, C.D. and Nguyen, C.T. and Nguyen, H.L.T. and Nguyen, L. and Noor, S.T.A. and Noreen, M. and Norouzy, A. and Nri-Ezedi, C.A. and Nwakama, C.N. and Nyande, F.K. and O'Connell, E.M. and Okonji, O.C. and Okunlola, J.O. and Olabisi, O.I. and Olorunsaiye, C.Z. and Onie, S. and Onwujekwe, O.E. and Orscelik, A. and Ortiz- Prado, E. and Osborne, A. and Osuagwu, U.L. and Ouyahia, A. and Padukudru Anand, M. and Padubidri, J.R. and Palma-Álvarez, R.F. and Pantazopoulos, I. and Parikh, R.R. and Parmar, A. and Pashaei, A. and Pasovic, M. and Patel, J. and Patel, S.K. and Patil, S. and Pawar, S. and Peprah, P. and Poluru, R. and Pourtaheri, N. and Pradhan, J. and Prates, E.J.S. and Puthussery, S. and Puvvula, J. and Qattea, I. and Qi, X. and Qi, Z. and Qiao, Y. and Raheem, K.A. and Rahimi-Movaghar, V. and Rahman, M.M. and Rahman, M.A. and Rahman, M.A. and Raimondo, I. and Rajaa, S. and Rajpoot, P.L. and Ramadan, M.M. and Ramazanu, S. and Ranabhat, C.L. and Rao, S.J. and Rathish, D. and Rauniyar, S.K. and Rezaeian, M. and Rhee, T.G. and Rodriguez, J.A.B. and Roever, L. and Ronfani, L. and Rony, M.K.K. and Ross, A.G.P. and Rouzbahani, H. and Rouzbahani, S. and Roy, P. and Roy, S. and Rudolf, R. and Sabet, C.J. and Saeed, M. and Saeed, U. and Sagar, R. and Sagoe, D. and Sahoo, P.M. and Sajadi, S.M. and Salihu, D. and Sameen, S. and Samy, A.M. and Santomauro, D.F. and Santric-Milicevic, M.M. and Sarkar, T. and Sarode, G.S. and Sarode, S.C. and Satpathy, M. and Sawhney, M. and Selvaraj, S. and Sethi, Y. and Shahab, M. and Shahid, S. and Shahwan, M.J. and Shaikh, M.A. and Shaikh, N. and Shamsi, A. and Shamsutdinova, A. and Shan, D. and Shanawaz, M. and Shannawaz, M. and Sharma, V. and Shetty, M. and Shetty, P.K. and Shi, W. and Shimul, M.M.H. and Shiri, R. and Shittu, A. and Shiue, I. and Shorofi, S.A. and Siddig, E.E. and Silva, G.C.B.D. and Singh, A. and Gill, B. and Sousa, M.A. and Stanikzai, M.H. and Stein, C. and Stein, D.J. and Stubbs, B. and Subramaniyan, V. and Suhaib, M. and Sullman, M.J.M. and Sun, J. and Swain, C.K. and Sudha Ty, T.Y. and Tabarés-Seisdedos, R. and Tabatabaei, S.M. and Tabche, C. and Tampa, M. and Tareke, M. and Taridashti, S. and Tasnim, A. and Temsah, M.-H. and Tesfu, A.A. and Thapar, R. and Muthu, M. and Tian, W. and Tovani-Palone, M.R. and Tran, T.H. and Tran, T.H. and Tromans, S.J. and Truppa, C. and Tsai, A.C. and Tsermpini, E.E. and Twalibu, A. and Bhaskaran, B. and Vally, Z. and Vasconcelos, N.M. and Vieira, A. and Villarreal-Zegarra, D. and Vinayak, M. and Vos, T. and Waheed, Y. and Walia, M. and Wang, Q. and Wang, W. and Wang, Y.-P. and Wickramasinghe, N.D. and Wiredu Agyekum, M. and Xie, W. and Xu, W. and Yahoo (Syed), S. and Yan, G. and Yang, Y. and Ye, P. and Yesodharan, R. and Yi, S. and Yismaw, Y.E. and Yon, D.K. and Yonemoto, N. and Yu, C. and Yunusa, U. and Zadey, S. and Zamagni, G. and Zandam, H. and Zeariya, M.G.M. and Zemariam, A.B. and Zhang, B. and Zhang, H. and Zhumagaliuly, A. and Zinchuk, M. and Zoromba, M.A. and Zyoud, S.H. and Gakidou, E. (2026) Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023 : a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, 407 (10523). pp. 31-52. ISSN 0140-6736

Abstract

Background Violence against women and against children are human rights violations with lasting harms to survivors and societies at large. Intimate partner violence (IPV) and sexual violence against children (SVAC) are two major forms of such abuse. Despite their wide-reaching effects on individual and community health, these risk factors have not been adequately prioritised as key drivers of global health burden. Comprehensive x§and reliable estimates of the comparative health burden of IPV and SVAC are urgently needed to inform investments in prevention and support for survivors at both national and global levels. Methods We estimated the prevalence and attributable burden of IPV among females and SVAC among males and females for 204 countries and territories, by age and sex, from 1990 to 2023, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2023. We searched several global databases for data on self-reported exposure to IPV and SVAC and undertook a systematic review to identify the health outcomes associated with each of these risk factors. We modelled IPV and SVAC prevalence using spatiotemporal Gaussian process regression, applying data adjustments to account for measurement heterogeneity. We employed burden-of-proof methodology to estimate relative risks for outcomes associated with IPV and SVAC. These estimates informed the calculation of population attributable fractions, which were then used to quantify disability-adjusted life-years (DALYs) attributable to each risk factor. Findings Globally, in 2023, we estimated that 608 million (95% uncertainty interval 518–724) females aged 15 years and older had ever been exposed to IPV, and 1·01 billion (0·764–1·48) individuals aged 15 years and older had experienced sexual violence during childhood. 18·5 million (8·74–30·0) DALYs were attributed to IPV among females and 32·2 million (16·4–52·5) DALYs were attributed to SVAC among males and females in 2023. IPV and SVAC were among the top contributors to the global disease burden in 2023, particularly among females aged 15–49 years, ranking as the fourth and fifth leading risk factors, respectively, for DALYs in this group. Among the eight health outcomes found to be associated with IPV, anxiety disorders and major depressive disorder were the leading causes of IPV-attributed DALYs, accounting for 5·43 million (–1·25 to 14·6) and 3·96 million (1·71 to 6·92) DALYs in 2023, respectively. SVAC was associated with 14 health outcomes, including mental health disorder, substance use disorder, and chronic and infectious disease outcomes. Self-harm and schizophrenia were the leading causes of SVAC-attributed burden, with SVAC accounting for 6·71 million (2·00 to 12·7) DALYs due to self-harm and 4·15 million (–1·92 to 13·1) DALYs due to schizophrenia in 2023. Interpretation IPV and SVAC are substantial contributors to global health burden, and their health consequences span a variety of individual health outcomes. Importantly, mental health disorders account for the greatest share of disease burden among survivors. Investing in prevention of these avoidable risk factors has the potential to avert millions of DALYs and considerable premature mortality each year. Our findings represent strong evidence for global and national leaders to elevate IPV and SVAC among public health priorities. Sustained investments are needed to prevent IPV and SVAC and to implement interventions focused on supporting the complex social and health needs of survivors. Funding Gates Foundation.